Candriam Luxembourg S.C.A.
Q4 2019 13F-HR/A Holdings
Net value change ($000)
+1,783,798
(23.6%)
New positions
76
Sold out positions
29
Turnover %
3.7%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q3 2019
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| MSFT | 88,206 | 34.7% |
| GOOGL | 56,164 | 35.8% |
| AAPL | 53,111 | 35.9% |
| AMGN | 42,375 | 24.1% |
| BABA | 41,826 | 32.5% |
| REGN | 40,065 | 35.0% |
| INTC | 34,999 | 149.4% |
| JPM | 33,671 | 75.3% |
| QCOM | 31,822 | 186.4% |
| DHR | 29,188 | 153.5% |
Top Reduces (Value $000, Stocks/ETFs)
| Ra Pharmaceuticals, Inc. | -24,371 | -83.9% |
| ARQULE INC | -13,491 | -75.1% |
| PRU | -11,257 | -49.8% |
| GPN | -9,930 | -64.4% |
| INFY | -9,786 | -70.5% |
| LW | -9,271 | -90.0% |
| NTR | -9,200 | -93.1% |
| ULTA | -9,146 | -90.4% |
| BEN | -8,907 | -60.5% |
| Sage Therapeutics, Inc. | -8,764 | -44.8% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|